Insufficient scRNA-seq data for expression of TAS2R20 at single-cell level.
Insufficient scRNA-seq data for expression of TAS2R20 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 90% | 46.02 | 2387 / 2642 | 57% | 1.15 | 400 / 705 |
breast | 99% | 88.98 | 455 / 459 | 48% | 0.97 | 535 / 1118 |
lung | 100% | 90.65 | 576 / 578 | 47% | 1.16 | 543 / 1155 |
thymus | 100% | 108.43 | 653 / 653 | 45% | 0.73 | 275 / 605 |
esophagus | 96% | 56.74 | 1385 / 1445 | 45% | 0.87 | 83 / 183 |
uterus | 100% | 146.39 | 170 / 170 | 41% | 0.76 | 187 / 459 |
pancreas | 94% | 39.12 | 309 / 328 | 43% | 0.84 | 76 / 178 |
kidney | 94% | 44.13 | 84 / 89 | 39% | 0.78 | 349 / 901 |
prostate | 100% | 91.59 | 245 / 245 | 30% | 0.46 | 149 / 502 |
bladder | 100% | 66.05 | 21 / 21 | 28% | 0.64 | 143 / 504 |
skin | 99% | 69.31 | 1782 / 1809 | 29% | 0.47 | 137 / 472 |
adrenal gland | 99% | 65.59 | 256 / 258 | 23% | 0.35 | 53 / 230 |
intestine | 99% | 77.02 | 961 / 966 | 23% | 0.43 | 119 / 527 |
ovary | 100% | 150.61 | 180 / 180 | 20% | 0.35 | 88 / 430 |
stomach | 94% | 45.56 | 339 / 359 | 15% | 0.41 | 43 / 286 |
liver | 93% | 41.68 | 210 / 226 | 9% | 0.14 | 36 / 406 |
spleen | 100% | 104.26 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 79.10 | 1180 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 63.28 | 1282 / 1335 | 0% | 0 | 0 / 0 |
muscle | 95% | 53.71 | 765 / 803 | 0% | 0 | 0 / 0 |
heart | 89% | 40.94 | 763 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 47% | 23.15 | 438 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 28% | 0.42 | 8 / 29 |
tonsil | 0% | 0 | 0 / 0 | 24% | 0.34 | 11 / 45 |
eye | 0% | 0 | 0 / 0 | 11% | 0.18 | 9 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0001580 | Biological process | detection of chemical stimulus involved in sensory perception of bitter taste |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0033038 | Molecular function | bitter taste receptor activity |
Gene name | TAS2R20 |
Protein name | Taste receptor type 2 Taste receptor type 2 member 20 (Taste receptor type 2 member 49) (T2R49) (Taste receptor type 2 member 56) (T2R56) |
Synonyms | TAS2R49 |
Description | FUNCTION: Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5 (By similarity). . FUNCTION: Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5. . |
Accessions | ENST00000570941.1 ENST00000538986.2 ENST00000634193.1 P59543 A0A0J9YXF7 |